Iovance Biotherapeutics, Inc. short interest in 2025
In 2025, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 20.34% of shares outstanding on 15 Jan 2025 to 30.00% on 31 Dec 2025, a change of +9.66 percentage points. The year's high was 30.32% on 15 Dec 2025 and its low 18.16% on 15 Sep 2025, averaging 23.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.67 days on 15 Dec 2025. Full history: Iovance Biotherapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 20.34% (15 Jan 2025)
- End of year
- 30.00% (31 Dec 2025)
- Change
- +9.66 pp
- High
- 30.32% (15 Dec 2025)
- Low
- 18.16% (15 Sep 2025)
- Average
- 23.81%
- Highest days to cover
- 12.67 (15 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 20.34% | 5.88 | |
| 31 Jan 2025 | 20.97% | 8.09 | |
| 14 Feb 2025 | 20.87% | 8.71 | |
| 28 Feb 2025 | 19.55% | 4.67 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 22.08% | 6.13 | |
| 31 Mar 2025 | 24.67% | 9.35 | |
| 15 Apr 2025 | 23.42% | 6.59 | |
| 30 Apr 2025 | 22.33% | 8.96 | |
| 15 May 2025 | 23.06% | 3.03 | 10-Q filed, results (8-K) |
| 30 May 2025 | 25.86% | 7.10 | |
| 13 Jun 2025 | 27.24% | 6.99 | |
| 30 Jun 2025 | 28.98% | 9.08 | |
| 15 Jul 2025 | 29.54% | 7.21 | |
| 31 Jul 2025 | 20.28% | 2.12 | |
| 15 Aug 2025 | 19.72% | 4.20 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 19.71% | 5.71 | |
| 15 Sep 2025 | 18.16% | 7.06 | |
| 30 Sep 2025 | 20.17% | 7.20 | |
| 15 Oct 2025 | 21.06% | 7.39 | |
| 31 Oct 2025 | 24.04% | 7.42 | |
| 14 Nov 2025 | 29.15% | 4.04 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 29.96% | 11.83 | |
| 15 Dec 2025 | 30.32% | 12.67 | |
| 31 Dec 2025 | 30.00% | 8.86 |
See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.